{
    "organizations": [],
    "uuid": "85443bed36ddbc5afa334c117517ca5ae789feca",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sihuan-pharmaceutical-holdings-pos/brief-sihuan-pharmaceutical-holdings-posts-fy-profit-attributable-of-rmb1-45-bln-idUSFWN1R812E",
    "ord_in_thread": 0,
    "title": "BRIEF-Sihuan Pharmaceutical Holdings Posts ‍FY Profit Attributable Of RMB1.45 Bln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd:\n* FY REVENUE RMB2.75 BILLION VERSUS RMB3.19 BILLION * ‍FY PROFIT ATTRIBUTABLE RMB1.45 BILLION VERSUS RMB1.71 BILLION\n* BOARD RECOMMENDS DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND OF RMB1.3 CENTS PER SHARE\n* ‍ RECOMMENDS FINAL CASH DIVIDEND OF RMB1.3 CENTS PER SHARE​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-27T06:23:00.000+03:00",
    "crawled": "2018-03-27T12:16:10.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "sihuan",
        "pharmaceutical",
        "holding",
        "group",
        "ltd",
        "fy",
        "revenue",
        "billion",
        "versus",
        "billion",
        "profit",
        "attributable",
        "billion",
        "versus",
        "billion",
        "board",
        "recommends",
        "declaration",
        "payment",
        "final",
        "cash",
        "dividend",
        "cent",
        "per",
        "share",
        "recommends",
        "final",
        "cash",
        "dividend",
        "cent",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}